Financhill
Back

Goldman Sachs Nasdaq-100 Premium Income ETF Vs. Rapt Therapeutics, Inc. Industry Stock Comparison

Buy
61

GPIQ
Goldman Sachs Nasdaq-100 Premium Income ETF

Last Price:
$52.88
Seasonality Move:
-1.01%
Sell
40

RAPT
Rapt Therapeutics, Inc.

Last Price:
$33.91
Seasonality Move:
-27.57%
Buy
61
Goldman Sachs Nasdaq-100 Premium Income ETF (GPIQ) is a Buy

Is Goldman Sachs Nasdaq-100 Premium Income ETF a Buy, Sell or Hold?

  • The current Goldman Sachs Nasdaq-100 Premium Income ETF [GPIQ] share price is $52.87. The Score for GPIQ is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • GPIQ is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Rapt Therapeutics, Inc. (RAPT) is a Sell

Is Rapt Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Rapt Therapeutics, Inc. [RAPT] share price is $33.87. The Score for RAPT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • RAPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GPIQ Stock Price Chart

What is Goldman Sachs Nasdaq-100 Premium Income ETF's stock price today?

RAPT Stock Price Chart

What is Rapt Therapeutics, Inc.'s stock price today?

  • The Rapt Therapeutics, Inc. share price today is $33.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAPT is experiencing slight buying pressure.

GPIQ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.12 Buy
Relative Strength Index (14 RSI): 49.26 Sell
Chaikin Money Flow: -1255183 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.49 - 53.43) Sell
Bollinger Bands (100): (51.13 - 53.27) Buy

RAPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.53 Buy
Relative Strength Index (14 RSI): 51.15 Buy
Chaikin Money Flow: 79100 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.58 - 35.84) Sell
Bollinger Bands (100): (16.83 - 33.91) Buy

GPIQ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.11 Sell
20-day SMA: 53.01 Sell
50-day SMA: 52.92 Sell
200-day SMA: 49.6 Buy
8-day EMA: 53.07 Sell
20-day EMA: 52.95 Sell
50-day EMA: 52.7 Buy
200-day EMA: 50.67 Buy

RAPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35 Sell
20-day SMA: 34.72 Sell
50-day SMA: 31.71 Buy
200-day SMA: 17.02 Buy
8-day EMA: 31.84 Buy
20-day EMA: 21.97 Buy
50-day EMA: 11.45 Buy
200-day EMA: 3.3 Buy

Goldman Sachs Nasdaq-100 Premium Income ETF Earnings Growth & GPIQ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rapt Therapeutics, Inc. Earnings Growth & RAPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.65 per share, and a decrease next year of $1.22 per share.

Goldman Sachs Nasdaq-100 Premium Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rapt Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):